-
-
Call more information
660-596-2224 -
This was written by Elizabeth A. M. Frost, MD Professor of Anesthesia Icahn School of Medicine at Mount Sinai New York, New York Many questions have arisen and much controversy has emerged regarding how much fluid should be given perioperatively, which fluids should be given, when they should be given, and whether outcomes can be […]
Read MoreThis is for our readers who practice pain management. Authors: Wojahn RD et al., J Bone Joint Surg Am 2014 Nov 19; 96:1849 Almost half of patients required no additional injections. The estimated lifetime risk for trigger finger is about 3% in the general population and as high as 10% in diabetic patients. Treatment options […]
Read MoreExcitement is mounting about a new class of drugs for migraine prevention. In one of the most recent developments, a new phase 2 trial of ALD403, a humanized monoclonal antibody directed against calcitonin gene-related peptide (CGRO) showed that the drug was safe and effective. Results also showed that adverse events associated with the drug were […]
Read MorePublished in Rheumatology International (Sep 2014) Authors: Bjersing J et al Fibromyalgia (FM) is characterized by generalized chronic pain and reduced pain thresholds. Disturbed neuroendocrine function and impairment of growth hormone/insulin-like growth factor-1 is common. However, the pathophysiology of FM is not clear. MicroRNAs are important regulatory factors reflecting interface of genes and environment. Our […]
Read MoreMemantine, a drug primarily used to treat patients with Parkinson’s disease and Alzheimer’s disease, reduced pain and improved quality of life in patients with fibromyalgia, according to a study published in Pain. “This is the first randomised, controlled study of memantine for the treatment of fibromyalgia,” write Bárbara Oliván-Blázquez, from the Department of Psychology and […]
Read More